David Anderson
Chief Tech/Sci/R&D Officer at VBI VACCINES INC.
Net worth: 2 959 $ as of 29/04/2024
David Anderson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VBI VACCINES INC. | Chief Tech/Sci/R&D Officer | 05/05/2016 | - |
VBI Vaccines (Delaware), Inc.
 VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Chief Tech/Sci/R&D Officer | 31/07/2015 | - |
Career history of David Anderson
Former positions of David Anderson
| Companies | Position | Start | End |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 31/12/2008 | 31/01/2009 |
Variation Biotechnologies, Inc. (Canada)
 Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Founder | - | - |
| VBI VACCINES INC | Chief Tech/Sci/R&D Officer | 24/07/2014 | - |
Variation Biotechnologies (US), Inc.
 Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Chief Tech/Sci/R&D Officer | 31/12/2008 | - |
| Founder | 31/12/2000 | - |
Training of David Anderson
| Harvard University | Doctorate Degree |
| University of California, Davis | Undergraduate Degree |
Statistics
International
| United States | 8 |
| Canada | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Founder | 2 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| VBI VACCINES INC. | Health Technology |
| Private companies | 4 |
|---|---|
Variation Biotechnologies (US), Inc.
Variation Biotechnologies (US), Inc. BiotechnologyHealth Technology Variation Biotechnologies (US), Inc. develops and manufactures vaccines for infectious diseases. It is dedicated to the innovative formulation, development and delivery of safe and effective vaccines that expand and enhance vaccine protection in both established and emerging markets. The company was founded by David E. Anderson and Adam Buckley in 2001 and is headquartered in Boston, MA. | Health Technology |
VBI Vaccines, Inc. /Old/
 VBI Vaccines, Inc. /Old/ BiotechnologyHealth Technology VBI Vaccines, Inc. is a biopharmaceutical company. It engages in the development of eVLP vaccine platform for the design of (e) virus-like-particle vaccines that closely mimic the target virus. The company also involves in the development of thermostable technology that enables the development of vaccines and biologics that can withstand storage or shipment at constantly fluctuating temperatures. VBI Vaccines was founded on July 25, 2014 and is headquartered in Cambridge, MA. | Health Technology |
VBI Vaccines (Delaware), Inc.
VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Health Technology |
Variation Biotechnologies, Inc. (Canada)
Variation Biotechnologies, Inc. (Canada) BiotechnologyHealth Technology Variation Biotechnologies, Inc. (Canada) is a Canadian company that was founded by David Evander Anderson and is part of VBI Vaccines, Inc. The company is based in Ottawa, Canada and engages in the manufacture of vaccines. | Health Technology |
- Stock Market
- Insiders
- David Anderson
- Experience
